News & Press Releases

Access the latest news about Lipidor, our current projects, publications and collaborations. Thank you for your interest in Lipidor!

Subscribe

May 9, 2025

Lipidor AB (publ) publishes annual report for 2024

STOCKHOLM, Sweden, 9th May 2025 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its annual report for the financial year 2024. The report is available on the company's website lipidor.se and in the attached pdf (in Swedish). To read the report in full (in Swedish) click…

December 20, 2023

Lipidor applies to the Indian Medical Products Agency to start a Phase III study of AKP02G2

STOCKHOLM, Sweden, 20th December 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that the company, through its…

December 5, 2023

Lipidor presents Nomination Committee

STOCKHOLM, Sweden, 5th December 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today presents its Nomination Committee, which shall…

November 30, 2023

Lipidor changes Certified Adviser to Carnegie Investment Bank AB (publ)

STOCKHOLM, Sweden, 30th November 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces a change of Certified Adviser…

November 22, 2023

Lipidor AB (publ) publishes interim report for Q3 2023

STOCKHOLM, Sweden, 22nd November 2023 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the…

October 27, 2023

Lipidor submits new patent application

STOCKHOLM, Sweden, 27th October 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that the company has filed…

October 18, 2023

Lipidor extends and expands cooperation with RELIFE

STOCKHOLM, Sweden, 18th October 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that a new agreement has…

September 20, 2023

Lipidor signs agreement for clinical phase III study

STOCKHOLM, Sweden, 20th September 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) has signed an agreement with Cliantha Research…

August 23, 2023

Correction: Lipidor AB (publ) publishes interim report for Q2 2023

STOCKHOLM, Sweden, 23 August 2023 – In Lipidor's interim report for the second quarter 2023, published today at 08:30, incorrect figures were…

August 23, 2023

Lipidor AB (publ) publishes interim report for Q2 2023

STOCKHOLM, Sweden, 23 August 2023 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the…

June 29, 2023

Lipidor – Announcement of short-term funding

STOCKHOLM, Sweden, 29th June 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces that financing of SEK 2 million…